[go: up one dir, main page]

GB201512829D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB201512829D0
GB201512829D0 GBGB1512829.1A GB201512829A GB201512829D0 GB 201512829 D0 GB201512829 D0 GB 201512829D0 GB 201512829 A GB201512829 A GB 201512829A GB 201512829 D0 GB201512829 D0 GB 201512829D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1512829.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mission Therapeutics Ltd
Original Assignee
Mission Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mission Therapeutics Ltd filed Critical Mission Therapeutics Ltd
Priority to GBGB1512829.1A priority Critical patent/GB201512829D0/en
Publication of GB201512829D0 publication Critical patent/GB201512829D0/en
Priority to HK18104692.3A priority patent/HK1245266B/en
Priority to ES16713043T priority patent/ES2864950T3/en
Priority to JP2017551189A priority patent/JP6708661B2/en
Priority to EP21156385.3A priority patent/EP3842427A1/en
Priority to EP16713043.4A priority patent/EP3277677B9/en
Priority to RS20210502A priority patent/RS61759B9/en
Priority to HRP20210791TT priority patent/HRP20210791T2/en
Priority to PT167130434T priority patent/PT3277677T/en
Priority to BR112017020900-4A priority patent/BR112017020900B1/en
Priority to KR1020177031166A priority patent/KR102578325B1/en
Priority to LTEP16713043.4T priority patent/LT3277677T/en
Priority to RU2017134901A priority patent/RU2717238C2/en
Priority to SM20210287T priority patent/SMT202100287T1/en
Priority to MYPI2017001206A priority patent/MY188957A/en
Priority to MDE20180120T priority patent/MD3277677T2/en
Priority to EP21190809.0A priority patent/EP3943490A1/en
Priority to SI201631157T priority patent/SI3277677T1/en
Priority to HUE16713043A priority patent/HUE054474T2/en
Priority to SG11201706542TA priority patent/SG11201706542TA/en
Priority to US15/558,632 priority patent/US10343992B2/en
Priority to AU2016240033A priority patent/AU2016240033B2/en
Priority to CN201680019213.6A priority patent/CN107484415B/en
Priority to MX2017012566A priority patent/MX373656B/en
Priority to PL16713043T priority patent/PL3277677T3/en
Priority to CN202110132842.2A priority patent/CN112707893B/en
Priority to NZ736450A priority patent/NZ736450A/en
Priority to CA2976741A priority patent/CA2976741C/en
Priority to DK16713043.4T priority patent/DK3277677T3/en
Priority to PCT/GB2016/050851 priority patent/WO2016156816A1/en
Priority to ZA2017/05717A priority patent/ZA201705717B/en
Priority to IL254721A priority patent/IL254721B/en
Priority to CONC2017/0011172A priority patent/CO2017011172A2/en
Priority to US16/297,937 priority patent/US11053198B2/en
Priority to US16/419,747 priority patent/US11066365B2/en
Priority to US16/419,558 priority patent/US10689345B2/en
Priority to US16/788,446 priority patent/US11390584B2/en
Priority to JP2020088995A priority patent/JP7216682B2/en
Priority to CY20211100441T priority patent/CY1124170T1/en
Priority to US17/709,556 priority patent/US20220251041A1/en
Priority to JP2022099677A priority patent/JP7389856B2/en
Ceased legal-status Critical Current

Links

GBGB1512829.1A 2015-03-30 2015-07-21 Novel compounds Ceased GB201512829D0 (en)

Priority Applications (41)

Application Number Priority Date Filing Date Title
GBGB1512829.1A GB201512829D0 (en) 2015-07-21 2015-07-21 Novel compounds
PCT/GB2016/050851 WO2016156816A1 (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
US15/558,632 US10343992B2 (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as USP30 inhibitors
AU2016240033A AU2016240033B2 (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as USP30 inhibitors
JP2017551189A JP6708661B2 (en) 2015-03-30 2016-03-24 1-Cyano-pyrrolidine compounds as USP30 inhibitors
EP21156385.3A EP3842427A1 (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
EP16713043.4A EP3277677B9 (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
RS20210502A RS61759B9 (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
HRP20210791TT HRP20210791T2 (en) 2015-03-30 2016-03-24 1-CYANO-PYROLIDINE COMPOUNDS AS USP30 INHIBITORS
PT167130434T PT3277677T (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
BR112017020900-4A BR112017020900B1 (en) 2015-03-30 2016-03-24 1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS AND THEIR USE, PHARMACEUTICAL COMPOSITION
KR1020177031166A KR102578325B1 (en) 2015-03-30 2016-03-24 1-Cyano-pyrrolidine compounds as USP30 inhibitors
LTEP16713043.4T LT3277677T (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
RU2017134901A RU2717238C2 (en) 2015-03-30 2016-03-24 Compounds of 1-cyano-pyrrolidines as usp30 inhibitors
SM20210287T SMT202100287T1 (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
MYPI2017001206A MY188957A (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
MDE20180120T MD3277677T2 (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
EP21190809.0A EP3943490A1 (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
SI201631157T SI3277677T1 (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
HUE16713043A HUE054474T2 (en) 2015-03-30 2016-03-24 USP30 inhibitor 1-cyanopyrrolidine compounds
SG11201706542TA SG11201706542TA (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
HK18104692.3A HK1245266B (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
MX2017012566A MX373656B (en) 2015-03-30 2016-03-24 1-CYANO-PYRROLIDINE COMPOUNDS AS INHIBITORS OF DEUBIQUITINATING ENZYMES, SUCH AS UBIQUITIN C-TERMINAL HYDROLASE 30 (USP30), AND THEIR USE IN THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION CONDITIONS AND CANCER TREATMENT.
ES16713043T ES2864950T3 (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as USP30 inhibitors
CN201680019213.6A CN107484415B (en) 2015-03-30 2016-03-24 1-cyanopyrrolidine compounds as USP30 inhibitors
PL16713043T PL3277677T3 (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
CN202110132842.2A CN112707893B (en) 2015-03-30 2016-03-24 1-cyanopyrrolidine compounds as USP30 inhibitors
NZ736450A NZ736450A (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
CA2976741A CA2976741C (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
DK16713043.4T DK3277677T3 (en) 2015-03-30 2016-03-24 1-cyano-pyrrolidine compounds as usp30 inhibitors
ZA2017/05717A ZA201705717B (en) 2015-03-30 2017-08-22 1-cyano-pyrrolidine compounds as usp30 inhibitors
IL254721A IL254721B (en) 2015-03-30 2017-09-26 1-cyano-pyrrolidine compounds as usp30 inhibitors
CONC2017/0011172A CO2017011172A2 (en) 2015-03-30 2017-10-30 1-Cyano-pyrrolidine compounds as usp30 inhibitors
US16/297,937 US11053198B2 (en) 2015-03-30 2019-03-11 1-cyano-pyrrolidine compounds as USP30 inhibitors
US16/419,747 US11066365B2 (en) 2015-03-30 2019-05-22 1-cyano-pyrrolidine compounds as USP30 inhibitors
US16/419,558 US10689345B2 (en) 2015-03-30 2019-05-22 1-cyano-pyrrolidine compounds as USP30 inhibitors
US16/788,446 US11390584B2 (en) 2015-03-30 2020-02-12 1-cyano-pyrrolidine compounds as USP30 inhibitors
JP2020088995A JP7216682B2 (en) 2015-03-30 2020-05-21 1-Cyano-pyrrolidine compounds as USP30 inhibitors
CY20211100441T CY1124170T1 (en) 2015-03-30 2021-05-20 1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS
US17/709,556 US20220251041A1 (en) 2015-03-30 2022-03-31 1-cyano-pyrrolidine compounds as usp30 inhibitors
JP2022099677A JP7389856B2 (en) 2015-03-30 2022-06-21 1-Cyano-pyrrolidine compounds as USP30 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1512829.1A GB201512829D0 (en) 2015-07-21 2015-07-21 Novel compounds

Publications (1)

Publication Number Publication Date
GB201512829D0 true GB201512829D0 (en) 2015-09-02

Family

ID=54064700

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1512829.1A Ceased GB201512829D0 (en) 2015-03-30 2015-07-21 Novel compounds

Country Status (1)

Country Link
GB (1) GB201512829D0 (en)

Similar Documents

Publication Publication Date Title
ZA201804739B (en) Novel compounds
IL255067A0 (en) Novel compounds
GB201516243D0 (en) Novel compounds
GB201522768D0 (en) Novel compounds
GB201521109D0 (en) Novel compounds
GB201506871D0 (en) Novel compounds
GB201501462D0 (en) Novel compounds
GB201510019D0 (en) Compounds
GB201522179D0 (en) Novel compounds
GB201504565D0 (en) Novel compounds
GB201508747D0 (en) Compounds
GB201514754D0 (en) Compounds
GB201514751D0 (en) Compounds
GB201508864D0 (en) Compounds
GB201502675D0 (en) Novel compounds
GB201510493D0 (en) Compounds
GB201503926D0 (en) Compounds
GB201501115D0 (en) Compounds
GB201508857D0 (en) Compounds
GB201521749D0 (en) Novel compounds
GB201521713D0 (en) Novel compounds
GB201516241D0 (en) Novel compounds
GB201512829D0 (en) Novel compounds
GB201512270D0 (en) Novel Compounds
GB201511842D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)